ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 263 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,957 | – | 425 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 916,353 | $17,245,763 | 6.59% |
| Baker Brothers Advisors | 41,938,486 | $789,282,307 | 4.29% |
| Palo Alto Investors LP | 2,405,793 | $45,277,024 | 3.75% |
| Birchview Capital, LP | 249,400 | $4,694 | 3.68% |
| EcoR1 Capital, LLC | 5,991,479 | $112,759,635 | 3.63% |
| RTW INVESTMENTS, LP | 8,242,864 | $155,130,700 | 3.23% |
| EMERALD ADVISERS, LLC | 1,496,560 | $28,165,259 | 1.35% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,207,302 | $22,721,424 | 1.34% |
| Frazier Life Sciences Management, L.P. | 857,338 | $16,135,101 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $4,060,800 | 1.13% |